Patients should monitor their skin regularly and seek dermatology evaluation for any new, changing, or concerning lesions
The small sample sizes ( n = 169 for T2D and n = 254 for obesity) compared to clinical trials, as well as a lack of representativeness in the study population relative to national prevalence rates, further undermine generalizability
The underlying science, that gut bacteria and SCFAs influence GLP-1, is real and well documented
Image for illustrative purposes only
These effects help mitigate -amyloid accumulation, tau hyperphosphorylation, and neuroinflammation, reinforcing metformins potential role in preventing AD comorbidity in DM2 patients
However, previously, widespread shortages of injectable GLP-1s such as Ozempic and Wegovy disrupted care